Does LAZERTINIB Cause Off label use? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Off label use have been filed in association with LAZERTINIB (LAZCLUZE). This represents 5.4% of all adverse event reports for LAZERTINIB.
19
Reports of Off label use with LAZERTINIB
5.4%
of all LAZERTINIB reports
0
Deaths
5
Hospitalizations
How Dangerous Is Off label use From LAZERTINIB?
Of the 19 reports, 5 (26.3%) required hospitalization, and 1 (5.3%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LAZERTINIB. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does LAZERTINIB Cause?
Rash (77)
Neuropathy peripheral (32)
Infusion related reaction (30)
Fatigue (26)
Diarrhoea (20)
Paronychia (16)
Pruritus (13)
Nausea (12)
Dyspnoea (11)
Oedema peripheral (11)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which LAZERTINIB Alternatives Have Lower Off label use Risk?
LAZERTINIB vs LEBRIKIZUMAB-LBKZ
LAZERTINIB vs LECANEMAB
LAZERTINIB vs LECANEMAB-IRMB
LAZERTINIB vs LECITHIN\POLOXAMER 407
LAZERTINIB vs LEDIPASVIR